| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/14/2008 | WO2008018785A1 Polar organic extract of eurycoma longifolia |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008017886A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| 02/14/2008 | WO2008017637A1 Drug combinations for the treatment of respiratory tract diseases |
| 02/14/2008 | WO2008017604A2 Sandalwood aroma receptors |
| 02/14/2008 | WO2008017598A2 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 02/14/2008 | WO2008017521A2 Compositions with enhanced elasticizing activity |
| 02/14/2008 | WO2008017331A2 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 02/14/2008 | WO2008002191A3 Means and method for enhancing a human sexual activity |
| 02/14/2008 | WO2007146124A3 Deuterated tadalafil derivatives |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039517 2-chloro-4-{[(3S)-1-methyl-5-oxo-3-pyrrolidinyl][(2-methylphenyl)methyl]amino}benzonitrile; for treatment of endometreosis, uterine fibroids, dysmenorrhea, menorrhagia, pre-term labor, or infertility |
| 02/14/2008 | US20080039384 Antiangiogenic Peptides |
| 02/14/2008 | US20080039372 Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation |
| 02/14/2008 | US20080038387 Therapy of estrogen-associated disorders |
| 02/14/2008 | US20080038350 Low-dosage peroral medication for contraception containing crystalline dienogest and ethinyl estradiol |
| 02/14/2008 | US20080038343 Pharmaceutical composition containing a tetrahydrofolic acid |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2660186A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/14/2008 | CA2659979A1 Reversible inhibition of sperm receptor synthesis for contraception |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659295A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | CA2655472A1 Compositions with enhanced elasticizing activity |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886694A1 Peroral formulation of dienogest and ethinylestradiol for contraception |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886676A1 Compositions with enhanced elasticizing activity |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1885333A1 Pharmaceutical formulation of apomorphine for buccal administration |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1353938B1 Androgenic 7-substituted 11-halogenated steroids |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | CN101124239A Modulation of ovulation |
| 02/13/2008 | CN101123956A Use of PPAR agonists to treat ruminants |
| 02/13/2008 | CN101121754A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 02/13/2008 | CN101120987A Blood-nourishing speckle-removing powder and preparation method thereof |
| 02/13/2008 | CN101120986A Body-clearing itching-relieving liquid |
| 02/13/2008 | CN101120916A Prostaglandin E2 injection and manufacturing method thereof |
| 02/13/2008 | CN100368436C Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368016C Infusion liquid for treating cow mastitis and preparation method thereof |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100368008C Chinese medicine for treating gynopathy and its preparing process |
| 02/13/2008 | CN100367993C Gamboge paste for treating cervical erosion |
| 02/13/2008 | CN100367958C Vaginal effervesce tablet of ornidazole and its preparation method |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367929C Preparation of Chinese traditional medicine for curing female inflammation and preparation method |
| 02/13/2008 | CN100367927C Drug delivery of phase changing formulation |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction |
| 02/12/2008 | CA2289260C Controlled release of drugs delivered by sublingual or buccal administration |
| 02/12/2008 | CA2261972C Method of breeding high-level lactation dairy cows using rumen-bypassed amino acids |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016039A1 Fertility agent |
| 02/07/2008 | WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | WO2008014722A1 Prenyl flavonoids,their preparation and use |
| 02/07/2008 | WO2007143425A3 Treatment of hot flashes using muscarinic receptor antagonists |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080031980 Curcumin-containing composition, methods of making, and methods of using |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | CN101120014A Modulation of ovulation |
| 02/06/2008 | CN101119732A Contraceptive pharmaceutical preparation |
| 02/06/2008 | CN101117335A Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 02/06/2008 | CN101116740A Chinese traditional medicine preparations for treating flatus vaginalis |
| 02/06/2008 | CN101116738A Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
| 02/06/2008 | CN101116735A Chinese traditional medicine preparations for treating trichomonal vaginitis |
| 02/06/2008 | CN101116725A Chinese traditional medicine preparations for treating oligohydramnios |
| 02/06/2008 | CN101116720A Chinese traditional medicine preparations for treating senile vaginitis |
| 02/06/2008 | CN101116704A Oral Chinese traditional medicine composition for treating dysfunctional uterine bleeding |
| 02/06/2008 | CN101116701A Chinese traditional medicine composition for treating trichomonal vaginitis |
| 02/06/2008 | CN101116693A Chinese traditional medicine for treating mammary cancer |
| 02/06/2008 | CN101116692A Medicine for treating hyperplasia of mammary glands |
| 02/06/2008 | CN101116687A Chinese traditional medicine pills for treating small intestine hernia and testis turgescence |
| 02/06/2008 | CN101116678A Medicinal composition for treating mammary gland hyperplasia and rhinitis and method for preparing the same |
| 02/06/2008 | CN101116677A Compound milettia reticulata capsule and method for preparing the same |
| 02/06/2008 | CN101116676A Method for preparing compound milettia reticulata particles |
| 02/06/2008 | CN101116666A Compositions of estrogen-cyclodextrin complexes |
| 02/06/2008 | CN101116663A Percutaneously absorbable preparation for treating male sexual disfunction and method for preparing the same |
| 02/06/2008 | CN101116657A Externally- used contraception emulsion and method for preparing the same |
| 02/06/2008 | CN101116656A Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
| 02/06/2008 | CN100366723C Medicinal wine |
| 02/06/2008 | CN100366628C Effective parts of fructus sophorae flavone production and use thereof |
| 02/06/2008 | CN100366275C Method for controlling quality of Yunnan red tablet |
| 02/06/2008 | CN100366255C Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |